26 of 27 COVID VACCINE STOCKS FALL on last day of 2020

Brutal loss on last day of the year. Everything down except little Generex which vaulted forward a full 27%. 

Generex's performance single-handedly added one percent to the overall average return moving it to a loss of only 2.7%. 

No stock had a double digit loss but several had high single digit losses lead by Dynavax - down over 9% followed by:  VBI, NanTKwest, Arcturus, Nanoviricides, Novavax, Moderna and Sorrento.

 

Arcturus gains some back. NanTKwest and VBI strong

A mildly positive day with an overall average gain of 1.3%.  15 stocks were up with 11 down. 

Arcturus mitigated some of the recent trauma with a 10% gain. Both NanTKwest and VBI Vaccines had strong 7% gains.

 

Arcturus collapses - down 54%

Arcturus collapses on some bad news. It fell a full 54% for one of the worst day of any COVID VACCINE STOCK ever. 

The overall average fell 4.7% as a result of this collapse. Without Arcturus the rest of the stocks still fell 2.8% for one of the toughest days we've seen - the second of two rough days in the last week of December.

Twenty-two stocks fell with five gaining ground.  OncoSec managed a nice gain of almost 9%. 

Other notable catastrophes for the day include: Vaxart, Nano Viricides, Inovio and NanTKwest - all with large single digit losses.

 

COVID CARNAGE: CureVac and NanTKwest get wrecked.

A real brutal day for COVID VACCINE STOCKS. The overall average loss reached 4.4% today. Curevac and NanTKwest lead the way down with 13% and 10% losses respectively. 

Fully 23 stocks lost ground with four of the smallest eight stocks eking out gains.

All of the 17 largest stocks lost ground - some significantly. 

Three key stocks -- Moderna, Biontech and Novavax all lost over 9%.

VBI, Translate Bio, Dynavax, Vaxart, Inovio, Sorrento and Arturus all had high single digit losses.

IMV had the best day by far with a 9% gain.

 

BOTTOM TEN STATIC - PDS Bio moves out

PDS Bio escapes the Bottom Ten with a gain of 22% in its total return since 

March 1. Atara falls in even though it eked out an overall gain of 5%. Tonix and Dynavax move up incrementally. 

 

NanTKwest flies! Moves to 6th overall. Novavax strong again.

NanTKwest is the story of the week with the biggest break out of any COVID VACCINE STOCK rocketing its overall return up more than 100% in one week. It was one of the few stocks that has been in the bottom ten and the top ten.

Novavax also re-established its plus 700% return rate with a large 28% addition to its overall return. Both Moderna and BioNTech faltered significantly along with Altimmune. VBI has been bumped out of the top ten with a drop in its return of 10% this week.

The average overall return of all 27 stocks stayed very much the same, gaining 1% to 153%.

 

Sorrento breaks out - up 18%. Novavax strong.

Thirteen stocks up today and 12 down. It was a good day overall with an average gain for all the stocks together of 1.4%. 

Sorrento had the biggest move with more than an 18% gain followed by Tonix with over a 15% gain. Novavax had a greater than 10% gain and Dynavax gained just under 10%.

Arcturus lead the group down with a 14% loss. CureVac lost 7%.

 

Moderna and Novavax fall - NanTKwest and OncoSec strong.

 

Rough day for COVID VACCINE stocks with 17 falling. The overall average loss was 1.4% which represents a pretty serious fall. The big boys, Moderna and Novavax lead the group down falling 9% and 7% respectively.

NanTKwest was up a full 10% with OncoSec up another 8% today to lead the way up.

Emergent Bio makes move in little changed BOTTOM TEN

E

Emergent Bio made a strong move - overall average moving from 51% to 74%. It moves up to 10th worst performer from ninth. Alnylam gained ground as well.

The poorest performer was PDS Bio, falling from a return of 81% down to 69%. Overall, the bottom ten was completely flat on average.

 

Top Ten COVID VACCINE STOCKS fade this week after recent historic moves

Strong Day - Onco Sec explodes upwards 21%.

A very strong day for these stocks. OncoSec had a breakout day -- up over 21%.

A lot of action for Novavax as Phase III results are pending. The number one COVID VACCINE STOCK gained another 9% today. 

Overall, the index gained 2.2% with 19 gainers and 8 losers.

Dynavax, Tonix, Translate Bio, Altimmune and VBI all had strong high single digit gains. 

GeoVax gave back another large piece of recent major advances, losing over 13% today.

 

Translate Bio slammed - down 21%. Heat Biologics and OncoSec up just under 10%

Twice as many Covid vaccine stocks fell as went up. The average loss was 2% overall. 

Translate Bio had its worst day this year, falling 21% after recent strong gains.

Both Arcturus and Moderna fell around 7% while Vir and Dynavax fell around 6%.

In contrast, Heat Biologics rocked forward with a return of just under 10% today. OncoSec also gained 8% to lead the gainers today.

 

Covid Stocks drift lower, lowing 0.8%. Geovax climbs 14%.

Covid stocks drift lower - the average was an 0.8% pullback. There were 15 stocks that fell and 12 went up. 

GeoVax continues to bounce around, today jumping up almost 14%.  Inovio was the only other stock with a significant gain today, climbing up almost 5%. 

Heat Biologics lead the way down, falling a full 7% while yesterday's winner, Altimmune gave back 6% as did Sorrento. Both Dynavax and Generex fell 5%.

 

BionTech falls and Altimmune goes on a run to start the week.

BionTech falls just as its vaccines get into some arms. 

Altimmune has promising day, breaking well in to the $13 range and getting a double digit gain to lead on the upside.  Translate Bio continues its recent strong run. VBIV also has a strong day, up just under 7%.

GeoVax gives back over 7% of recent gains and NantKwest and Inovio fall almost 6% each.

 

PDSB and IMV fall back on quiet week for BOTTOM TEN

PDS Bio back into the BOTTOM TEN with a big fall this week as Adaptive climbs out.

iBio next worst performer, but holds on to its spot as third from worst.

IMV and EBS switch spots after IMV's tough week - its overall return falling from a loss of 39% to a loss of 51% since March 1.

Novavax back home in Number One spot. Translate Bio biggest move.

Arcturus' stay in the number 1 spot was short-lived. Novavax skipped ahead with a gain of 8% overall return since March 1, while Arcturus fell back 44% from its explosive moves the previous weeks. It still has a total return of 665% since March 1 while Novavax has returned 681%. Novavax has held title to the top spot except for a few short-lived absences.

Translate Bio's return was up 39% to move it from 10th to 7th. GeoVax also moved back into the top ten with a move of 38% this week. This bumped out Inovio from the group.

Both Moderna and BionTech had strong weeks with Moderna the third best stock, now with a return of 505% since March 1. 

It was a strong week with the overall average of all these stocks up from 141% to 160%. 

 

Arcturus roars back - 18% gain.

Bouncy day with some big winners and some big losers. Overall the stocks averaged a 0.2% gain with 15 stocks up and 12 down.

Little Geovax gave back a big chunk of the huge gain yesterday, falling over 26%. Heat Biologics also was hit with a 12% crater.  CureVac and iBio were hit hard today.

Arcturus got back to its winning ways with a strong 18% gain.  Vir had its best day in a long while with a greater than 9% gain.

NantKwest, Adaptive, BioNTech and IMV also had strong high single digit gains.

GeoVax up 79% - Rest collapse

Train wreck of a day for COVID VACCINE STOCKS. Fully 24 of 27 fell, some by a lot. However, the overall average was only a loss of 0.6% thanks to the freaky blowing up of little GeoVax which literally went up 79%.

PDS Bio fell almost 12%. Arcturus and Atra fell 11%. Moderna and TBIO fell 8%.

Altimmune and NantKwest fell 7%. Brutal day.
 

CureVac rolls on - up 14%. Arcturus hammered 19%.

Mostly flat day with an overall average loss of 0.2%. There were quite notable exceptions. CureVac took its turn in the sun with a stellar gain of almost 14%. 

Moderna continued its amazing run - now the company is worth over $67B in market cap with another 6% gain today. 

Arcturus gave back a big chunk of recent gains with a 19% drop. iBio was also hammered, losing almost 13%. 

Tonix fell over 7% to post the third biggest loss for the day.
 

GeoVax and NanTKwest lead the way up to start the week

The overall average was up 2.1% today for a relatively strong day. Several Covid Vaccine Stocks had spectacular day. 

Geovax lead with an 18% gain followed by NanTKwest with a greater than 13% move upward. 

Adaptive Bio, Tonix and Arcturus also had double digit gains.

PDSB lead the way down with a 11% drop and Dynavax dropped almost 8%. 

Fourteen stocks were up and 13 down.

 

CureVac moves out of BOTTOM TEN with strong week

All the action is at the top end not down here at the bottom.

CureVac rocks its way out of the BOTTOM TEN. Other than that, not much action.

NEW #1 -- Arcturus!!

For the first time since July 18, Novavax is not the number 1 COVID VACCINE STOCK. 

Arcturus has exploded up to the top spot. Arcturus has now returned 709% since March 1. This is a gain percentage return of 260% just this week. This is the best week any COVID VACCINE STOCK has ever had.

The other emerging major winner is Moderna. Its gain has gone from 390% to 488%.

Altimmune, Translate Bio and OncoSec also had decent weeks, but not like the big guns:  Arcturus and Moderna.

 

PDSB and Arcturus lead the group up on flat Friday.

More than half of the gain today comes from two stocks: PDSB and Arcturus. The overall average was a gain of 1.6%. 13 stocks were up and 12 down with two flat.

Altimmune was the poorest performer - down almost 4%.

 

Arcturus and Moderna lead the way.

Arcturus flies up 19% to lead the way. Moderna was up another 10% as it continues its amazing run. Overall, the stocks averaged a gain of 0.8% with 13 up and 13 down.

Both Altimmune and Vaxart had strong upper single digit gains.

 

Altimmune tanks, iBio strong on overall Flat Day

Almost completely flat day - overall average was a gain of less than 0.1% with 14 up and 13 down.

The big loser was yesterday's winner: Altimmune, giving back almost all of yesterday's gain - falling a whopping 14%. 

iBio was the winner, closing up just under 10%. OncoSec, BionTech and CureVac all had high single digit gains.

 

Bounce down day after strong performance yesterday. Altimmune strong

It was a back to earth today after the recent explosions upward. The overall average was a drop of 2.2%. 

15 stocks were down and 11 up. 

Altimmune had a double digit gain, going up 13%. That was the only strong performance today.

Novavax and Arcturus gave back 11% while Moderna, BionTech, CureVac, VBI and IMV had high single digit losses.

 

EXPLOSION UP CONTINUES - MODERNA in charge!

Amazingly powerful upsurge in COVID VACCINE STOCKS. These are the days we dreamed of when we got interested in these stocks. 

21 were up - some a lot and six down. The overall average return was an amazing 7.5% were one of the best days yet. 

CureVac had the best day of all with a gain 22%. Moderna had another explosive day on even better news about its vaccine. It has quickly got over the $60B level in market value. It was in the low 20's just a few weeks ago.

Arcturus gained over 20% as well.

VBI, Altimmune, Biontech and Novavax had double digit gains as well.

 

Not much action in the BOTTOM TEN - All the action is up Top

 

Bottom Ten have a very flat week, unlike the Top Ten. 

EBS slips another slot to just 8th worst overall. Ibio flips with Virology.

Thanksgiving week is amazing blow out week for the TOP TEN - NOVAVAX soars!

Up Up and Away. Novavax has a total blow out week. It had the best week of any COVID VACCINE STOCK ever.

It went from a measly return of 441% to a return of 686%. 

All other stocks in the TOP TEN do exceptionally well also. Arcturus and Moderna moved up over 100% in total return. 

The only change in ranking is Sorrento slipping ahead of OncoSec into 4th. 

 

EXPLOSIVE THANKSGIVING RALLY - NANTKWEST, ARCTURUS, NOVAVAX and MODERNA LEAD THE WAY!!

The Wednesday before Thanksgiving (November 25, 2020) will do down as the greatest buying opportunity for COVID VACCINE STOCKS.

In a half-day of trading, these stocks exploded up by just under 9%. Every last one except NanoViricides registered a gain.

The number one stock on this blow-out day was NantKwest which gained over 28%. Arcuturus was up over 25%.  Our number one stock, Novavax had its best day in many months with an enormous 22.5% gain. Moderna had a monster day, climbing over the $50B market value level, adding another 16%. 

Sorrento and Inovio both had enormous 18% gains. 

WOW!!

 

Huge day for Heat Biologics and Moderna

Huge day for Moderna as it gets the OK from EU. It's been a long time since Moderna had a double digit gain -- going up by almost 11%. Heat Biologics performed even better: escalating almost 16%. 

Both VBI and Altimmune were up 9% and Novavax was up just under 8%.

Overall, the stocks had a very strong day - up 2.5% on average.

There were 17 stocks that went up and 10 down.

 

COVID VACCINE STOCKS crumble - fall almost 3%

Carnage for COVID VACCINE STOCKS. On the day the DOW crosses 30,000 for the first time, these stocks crumble.

The overall average was a loss of 2.8%.  Only three stocks managed to eek out a small gain.

Vaxart reversed from yesterday, leading the way down with a 12% loss.  VBI fell 8.5%, Generex fell 8.1%, Sorrento down 6.2% and Heat Biologics down an even 5%.

 

Top Stocks do well, the smaller ones lag. Vaxart is #1 today.

The top vaccine stocks do well today, while most of the smaller ones have a poor day. Only nine were up with 18 down. 

The overall average was a gain of 0.25%.

Vaxart lead the way up with a strong gain of 11.17%. 

Novavax has a strong day up 8.58%. CureVac was up just under 7%. OncoSec was also up over 5%.

iBio had the worst day overall with a loss of over 9%. Generex, NanTKwest and Dynavax had high single digit losses.

 

Flat week for BOTTOM TEN - ATARA moves up

IMV falls into BOTTOM TEN after its return since March falls from 63% to 57%. Atara Bio has climbed to 14th overall with another 40% gain. It has moved from returning 11% two weeks ago to 89%.

CureVac was the top gainer, moving its return up 8%.

 

Moderna and Sorrento making a move towards the top. Translate Bio back in TOP TEN.

Dramatic twists and turns in the top ten. This is becoming a scary stock picker environment. There were three major winners and the rest lost ground - some serious ground. 

In the week of Moderna's Phase III announcement, it went from a return of 245% to 276%, remaining in third place overall. The biggest gainer was Sorrento which went from a 197% return to 248%. This is one of the most volatile of all the COVID VACCINE STOCKS.

Translate Bio went from a return of 111% up to 142% to return to the TOP TEN for the first time since June 28. It's one of the few of these stocks that have moved from the bottom ten to the top ten.

The top two, Novavx and Arcturus, along with OncoSec (4th) had the worst weeks, with their respective returns moved down over 50%.

 

An overall positive day - 1.1% gain for the day. BionTech and Vaxart lead the way.

Another modestly higher day for COVID VACCINE STOCKS as they put together a 1.1% overall gain on average. 

14 stocks gained ground and 13 fell.

BionTech continued its volatility since the announcement last week, today volatility on the upside, gaining just under 10%.  Vaxart was next with over an 8% gain.

Both CureVac and Moderna had strong days gaining almost 6%. Moderna is nearing its highest ever market value - over $38 B.

On the downside, Generex fell 6% to lead the way down. Inovio fell 4% to end to finish the week with a loss.

 

Sorrento goes up almost 12% on relatively positive day

A relatively up day with an overall average gain of 1.3%.  17 stocks were up and nine down with one flat.

Sorrento lead the way up with a gain of almost 12%. Generex, Atara and Arcturus had high single digit gains.

Adaptive Biotech fell over 6% to lead the way down.

 

Flat Day - Generex up 16%

Flat day for COVID VACCINE STOCKS overall. There were 17 that fell and 10 that gained ground.

The top performer was Generex, which leapfrogged up 16%. Arcturus also had a strong day, up over 6%. Adaptive was up almost 6%. 

Inovio lead the way down, falling 5.6%. Emergent was also a big loser, falling 5.4%. Dynavax also fell around 5%.

 

Stocks fall 1% on average. iBio gets hammered, falling almost 17%. VBI up almost 8%.

COVID VACCINE STOCKS fall 1% on average after a few tumultuous days. iBio got hammered, falling 16.59% to lead the way down. CureVac also had a double digit loss, falling almost 11%. Inovio fell just under 9%. BionTech continued its recent downward trajectory by falling 5%. 

On the upside, VBI gained almost 8%.

 

Moderna's big day - iBio, CureVac and Inovio also break out.

On the day of Moderna's big announcement, COVID VACCINE STOCKS advance an average of 1.6% with 13 up and 14 down.

There was significant volatility again with clear winners and losers. iBio was the biggest gainer, up over 15%, Inovio up 14.5% and CureVac p 14%. Moderna ended up 9.6% to reach its highest level yet -- a market cap of almost $39 B.

The biggest loser was last week's biggest winner: BionTech which fell almost 14%. Altimmune and OncoSec were down 7% and another of the big boys, Novavax fell 6%.

 

Atara and CureVac explode up

Atara and CureVac had great weeks and moved up the charts. Otherwise few changes on the BOTTOM TEN.

 

Radical week for COVID VACCINE STOCKS - Big Boys soar

 

A very tumultuous week. The winners really won and the losers really lost. Novavax has continued a two week surge seeing its return go up 42% this week after going up 58% the previous week. It has return of over 500% since March 1.

But the biggest week went to the biggest COVID VACCINE stock: Moderna. Its return went from 179% up to 245%. It has rocketed from 7th to 3rd overall.

OncoSec also had a great week, moving to second overall for the first time. Its return went up 42% from 265% to 307%.

BionTech had a great week as well, moving from 8th to 6th.

Arcturus got hammered this week, falling from second overall to fourth, with total return falling 114%. Altimmune also stumbled badly, falling from fifth to eighth, loosing fully 62% of total return this week. 

VBI leads the way up today with a 10% gain.

Another relatively positive day with stocks moving up 1.6% on average. 16 of the stocks went up with 11 down.

VBI was the big winner, up just under 10%. CureVac, Tonix, Novavax and Sorrento gained in the high single digits. Altimmune and Vaxart were the losers today with losses just under 5%.

 

Vaxart and Atara up over 15% - IMV down 13%.

Severe volatility continues for COVID VACCINE STOCKS. Thirteen stocks were up and 14 down. The overall average was a gain of just 1%, but that masks some radical moves both up and down.

Vaxart and Atara exploded up over 15% to lead the way. Generex, Novavax, Altimmune, Moderna and Inovio all had high single digit returns.

On the other hand, IMV lost 13.4% to lead the way down. Dynavax, BionTech, Adaptive, Sorrento and PDS all had high single digit losses.

 

Amazing bounce back day again - Arcturus up 24%

Amazing bounce back - COVID VACCINE STOCKS rock forward lead by Arcturus with an amazing 24% leap.

Fully five stocks had double digit gains: Vaxart, VBIV, Sorrento, Adaptive and OncoSec. Several more had high single digit returns: Moderna, Novavax, Vir, Dynavax, Altimmune and PDS Bio.  Moderna has reached its highest market value ever.

The average return was 4.7% which marks a superior day. Fully 21 moved forward with five slipping and one flat.

 

Huge Bounce Back Day - Inovio explodes up!

Amazingly strong bounce back day for COVID VACCINE STOCKS -- an overall average gain of 5.5%. This is one of the best days yet. 

Inovio exploded up 35% to lead the way. Altimmune got more than half of its dreadful collapse yesterday back, climbing 19%. 

Arcturus also bounced back with an almost 14% gain.  CureVac had a 12% gain, Vaxart up 11% and NantKwest up 10%.

Atara, Translate Bio, BionTech, Dynavax, iBio, IMV, OncoSec and GeoVax had high single digit gains.

Major mRna stocks, Novavax was down almost 13% and Moderna fell 2%.

 

BionTech up 14% - Terrible Day otherwise.

WHAT A DAY! WHAT A DEVASTATING DAY!! 

On the day BioNTech announced essentially that it has won the race, it went up 14% - was as high as 30% in the pre-market - and much of the rest of the market met their Waterloo. 

The average stock fell 8%. That is flat out as bad as it gets. 

Arcturus, which was #2 overall on the TOP TEN COVID VACCINE STOCK got murdered - falling 45%!! Altimmune lost 37%. Vaxart fell 32%. Let that sink in.

Vir lost 21%. Inovio, Sorrento, NantKwest, PDS Biotech all suffered double digit losses. Most of the rest also got hit hard as well.

CureVac and Moderna had their best days in months with gains of 8% and 7% respectively.  The rest is all bad news.

 

Flat week for the BOTTOM TEN. Dynavax moves to positive territory.

For all the turbulence out there, it was a very flat week for the BOTTOM TEN COVID VACCINE STOCKS. Dynavax was the top performer, with its return going up 10% from -5% to +5%, so we are left with six stocks who lost value since March 1.

Emergent Biosolutions fell into the bottom ten, replacing IMV. Its return at 67%.

 

Bounce back week for COVID VACCINE STOCKS - OncoSec emerges

Bounce back for COVID VACCINE STOCKS this week. OncoSec almost doubled in value and moved up from sixth to third overall. Novavax had a definite bounce back week with a move from 404% return to 462%. Arcturus is emerging as one of the best, moving up to second overall, going from a return of 290% to 357%. 

Sorrento was second in the top ten recently and now is in sixth.

The total return of all COVID VACCINE STOCKS climbed back over the 100% mark to 104%.